IL-35 inhibits human osteoclastogenesis from monocytes induced by receptor-activator of NF-κB ligand

IL-35 is known as a regulatory cytokine produced by regulatory T cells. It has also been reported that IL-35 suppresses the proliferation of Th17 cells, which is involved in the pathogenesis of many autoimmune diseases. However, in rheumatoid arthritis patients, the role of IL-35 is controversial, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yago, Toru, Nanke, Yuki, Kawamoto, Manabu, Kobashigawa, Tsuyoshi, Yamanaka, Hisashi, Kotake, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Society of Experimental and Clinical Immunology 2018
Materias:
Clinical Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102623/
https://www.ncbi.nlm.nih.gov/pubmed/30135626
http://dx.doi.org/10.5114/ceji.2018.77384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102623/
https://www.ncbi.nlm.nih.gov/pubmed/30135626
http://dx.doi.org/10.5114/ceji.2018.77384

Ejemplares similares